November 12-14, 2012 – Fall Intellectual Property
Counsels Committee (IPCC) Conference (Biotechnology
Industry Organization) – Charleston, SC

November 14, 2012 – Patents and
the Public Good (Greater Washington, DC Chapter of the Licensing
Executives Society) – Washington, DC

November 15, 2012 – Successful Strategies for Overcoming Obviousness Rejections in the Patent
Application Process (McDonnell
Boehnen Hulbert & Berghoff LLP) – 10:00 – 11:15 am
(CT)

November 27, 2012 – Patents and the Written Description Requirement: Navigating
Section 112 Disclosure Obligations and Withstanding Invalidity Challenges (Strafford) – 1:00 – 2:30 pm (EST)

November 28-29, 2012 – Biotech Patents*** (American Conference
Institute) – Boston, MA

November 28-29, 2012 – Orphan Drugs and Rare Diseases*** (American Conference
Institute) – Boston, MA

December 3-5, 2012 – Drug and Medical Device
Litigation*** (American Conference
Institute) – New York, NY

December 4-5, 2012 – Paragraph IV Disputes*** (American Conference
Institute) – San Francisco, CA

December 11, 2012 – Preissuance Prior Art Submissions at the USPTO — Best Practices
for Third-Party Challenges to Patent Applications and Monitoring
Competition (Strafford) – 1:00 – 2:30 pm (EST)

January 23-24, 2013 – The Comprehensive Guide to Patent Reform*** (American Conference
Institute) – New York, NY

January
29-30, 2013 – Biotech & Pharma Patent Litigation*** (C5) – Amsterdam, Netherlands

***Patent Docs is a media partner of this conference or CLE